Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 734

1.

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.

Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040. Review.

2.

Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.

Meng Y, Ward S, Cooper K, Harnan S, Wyld L.

Eur J Surg Oncol. 2011 Jan;37(1):40-6. doi: 10.1016/j.ejso.2010.10.001. Epub 2010 Nov 27.

PMID:
21115232
3.

Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.

Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM.

Health Technol Assess. 2014 Sep;18(59):1-120. doi: 10.3310/hta18590. Review.

4.

Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.

Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Eur J Surg Oncol. 2011 Mar;37(3):187-98. doi: 10.1016/j.ejso.2011.01.003. Epub 2011 Jan 26. Review.

PMID:
21269795
5.

Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.

Meads C, Auguste P, Davenport C, Małysiak S, Sundar S, Kowalska M, Zapalska A, Guest P, Thangaratinam S, Martin-Hirsch P, Borowiack E, Barton P, Roberts T, Khan K.

Health Technol Assess. 2013 Mar;17(12):1-323. doi: 10.3310/hta17120. Review.

6.

A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.

Huxley N, Jones-Hughes T, Coelho H, Snowsill T, Cooper C, Meng Y, Hyde C, Mújica-Mota R.

Health Technol Assess. 2015 Jan;19(2):v-xxv, 1-215. doi: 10.3310/hta19020. Review.

7.

Magnetic resonance for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis.

Harnan SE, Cooper KL, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Ingram C, Lorenz E, Wilkinson ID, Wyld L.

Eur J Surg Oncol. 2011 Nov;37(11):928-36. doi: 10.1016/j.ejso.2011.07.007. Epub 2011 Aug 19. Review.

PMID:
21855267
8.

PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.

Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M.

Cochrane Database Syst Rev. 2014 Nov 13;(11):CD009519. doi: 10.1002/14651858.CD009519.pub2. Review.

PMID:
25393718
9.

MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.

Liang X, Yu J, Wen B, Xie J, Cai Q, Yang Q.

Clin Radiol. 2017 Apr;72(4):295-301. doi: 10.1016/j.crad.2016.12.001. Epub 2017 Jan 27.

PMID:
28139203
11.

The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.

Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.

Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350. Review.

12.

An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Auguste P, Barton P, Hyde C, Roberts TE.

Health Technol Assess. 2011 Apr;15(18):iii-iv, 1-54. doi: 10.3310/hta15180. Review.

13.

Axillary treatment for operable primary breast cancer.

Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW.

Cochrane Database Syst Rev. 2017 Jan 4;1:CD004561. doi: 10.1002/14651858.CD004561.pub3. Review.

PMID:
28052186
14.

A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis L, Arvanitis T, Deeks J, Hyde C.

Health Technol Assess. 2010 Oct;14(50):1-103. doi: 10.3310/hta14500. Review.

15.

Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.

Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.

Acta Radiol. 2015 Aug;56(8):917-23. doi: 10.1177/0284185114539786. Epub 2014 Jul 10.

PMID:
25013091
16.

A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.

Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A.

Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420. Review.

17.

Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.

Verry H, Lord SJ, Martin A, Gill G, Lee CK, Howard K, Wetzig N, Simes J.

Br J Cancer. 2012 Mar 13;106(6):1045-52. doi: 10.1038/bjc.2012.62.

18.

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.

Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR.

Ann Surg Oncol. 2004 Sep;11(9):846-53. Epub 2004 Aug 16.

PMID:
15313737
19.

FDG-PET for axillary lymph node staging in primary breast cancer.

Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. Epub 2004 May 5. Review.

PMID:
15133635
20.

Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

PMID:
23002144

Supplemental Content

Support Center